SBRT showed improved LPFS over RFA in treating single recurrent small HCC, especially for tumors ≤2 cm. Both SBRT and RFA demonstrated similar PFS, OS, and safety profiles, with mild to moderate side ...

SBRT demonstrates high local control rates for larger RCC tumors, outperforming other ablative methods in terms of efficacy and safety. All ablative methods, including radiofrequency, microwave, and ...

SBRT administered to oligometastases was associated with survival benefits in phase 2 trial participants with CRPC receiving abiraterone and ADT. For patients with oligometastatic castrate-resistant ...

Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma In this trial, patients with recurrent small HCC (single lesion ≤5 cm) were randomly assigned to receive either SBRT or RFA.

A recent retrospective study found that pancreatic stereotactic body radiotherapy (SBRT) was associated with a low 90-day mortality rate, but early hospitalizations and adverse events, including ...